Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Goodwill & Intangibles (2013 - 2026)

Xencor (XNCR) posted quarterly Goodwill & Intangibles of $7.6 million for Q1 2026, down 43.11% year-over-year from $13.4 million in Q1 2025, and down 9.34% quarter-over-quarter from $8.4 million in Q4 2025.

Analysis

Xencor (XNCR) Goodwill & Intangibles (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Goodwill & Intangibles for 14 consecutive years, with $7.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles fell 43.11% year-over-year to $7.6 million; the TTM figure through Mar 2026 stood at $7.6 million (down 43.11% YoY), while the FY2025 annual figure was $8.4 million, down 54.64% from the prior year.
  • Goodwill & Intangibles eased to $7.6 million in Q1 2026 per XNCR's latest filing, from $8.4 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $18.9 million in Q1 2024 and bottomed at $7.6 million in Q1 2026.
  • Historically, Goodwill & Intangibles has averaged $15.9 million across 5 years, with a median of $18.1 million in 2022.
  • Annual changes were most pronounced in 2022 — Goodwill & Intangibles climbed 12.17% — and 2025, when it sank 54.64%.
  • Xencor's Goodwill & Intangibles stood at $18.5 million in 2022, then climbed by 0.88% to $18.7 million in 2023, then retreated by 0.95% to $18.5 million in 2024, then tumbled by 54.64% to $8.4 million in 2025, then decreased by 9.34% to $7.6 million in 2026.
  • Business Quant data shows XNCR's Goodwill & Intangibles at $7.6 million in Q1 2026, $8.4 million in Q4 2025, and $9.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Xencor 2.02 Bn 1.65 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.52 Mn
Mar 31, 2026 7.60 Mn
Dec 31, 2025 8.39 Mn
Sep 30, 2025 9.47 Mn
Jun 30, 2025 11.25 Mn
Mar 31, 2025 13.36 Mn
Dec 31, 2024 18.49 Mn
Sep 30, 2024 17.92 Mn
Jun 30, 2024 18.78 Mn
Mar 31, 2024 18.85 Mn
Dec 31, 2023 18.66 Mn
Sep 30, 2023 18.74 Mn
Jun 30, 2023 18.71 Mn
Mar 31, 2023 18.24 Mn
Dec 31, 2022 18.50 Mn
Sep 30, 2022 18.09 Mn
Jun 30, 2022 17.94 Mn
Mar 31, 2022 16.71 Mn
Dec 31, 2021 16.49 Mn
Sep 30, 2021 16.68 Mn